PET-Computed Tomography in the Management of Sarcoma by Interventional Oncology.
Authors
Affiliations (2)
Affiliations (2)
- Penn Image-Guided Interventions (PIGI) Laboratory, Department of Radiology, Perelman School of Medicine, Hospital of University of Pennsylvania, Philadelphia, PA 19104, USA. Electronic address: [email protected].
- Penn Image-Guided Interventions (PIGI) Laboratory, Department of Radiology, Perelman School of Medicine, Hospital of University of Pennsylvania, Philadelphia, PA 19104, USA.
Abstract
PET-computed tomography (CT) has become essential in sarcoma management, offering precise diagnosis, staging, and response assessment by combining metabolic and anatomic imaging. Its high accuracy in detecting primary, recurrent, and metastatic disease guides personalized treatment strategies and enhances interventional procedures like biopsies and ablations. Advances in novel radiotracers and hybrid imaging modalities further improve diagnostic specificity, especially in complex and pediatric cases. Integrating PET-CT with genomic data and artificial intelligence (AI)-driven tools promises to advance personalized medicine, enabling tailored therapies and better outcomes. As a cornerstone of multidisciplinary sarcoma care, PET-CT continues to transform diagnostic and therapeutic approaches in oncology.